Leadership changes sits at the center of this dementia and brain health question.
Leadership changes across major Alzheimer’s care organizations in 2025 and early 2026 signal significant organizational growth and expansion in the dementia care field. In January 2026, HHS Secretary Robert F. Kennedy, Jr.
appointed a new Chair and 10 new members to the Advisory Council on Alzheimer’s Research, Care, and Services, bringing fresh expertise in aging services and dementia advocacy. Simultaneously, major organizations like the Alzheimer’s Drug Discovery Foundation, Alzheimer’s Association, and regional providers like Alzheimer’s Los Angeles have undergone leadership transitions or strategic expansions, reflecting a broader shift toward scaling dementia care services nationwide. This article examines what these leadership changes reveal about the state of Alzheimer’s care, how they’re reshaping the field, and what they mean for patients, families, and healthcare professionals.
Table of Contents
- What Do Leadership Changes Tell Us About Organizational Growth?
- Federal Leadership Expansion and Its Real-World Implications
- Leadership Transitions at Major Alzheimer’s Organizations
- How Expanded Leadership Translates to Better Patient Care
- Scaling Challenges and the Reality of Expanding Dementia Care
- Professional Education as a Growth Priority
- Looking Forward: What These Leadership Changes Suggest About the Field’s Direction
- Conclusion
What Do Leadership Changes Tell Us About Organizational Growth?
Leadership transitions at established organizations rarely happen without strategic intention. When major Alzheimer’s care providers and advocacy groups change leadership or expand their boards, it typically signals preparation for growth, new program launches, or a shift in organizational priorities. The appointment of experienced leaders like Kristi Putnam—who served as Arkansas Department of Human Services Secretary from January 2023 to July 2025 and brings 25+ years of hands-on experience in human services and aging—to federal advisory positions indicates that organizations are prioritizing individuals with proven track records in scaling services. Her appointment reflects a deliberate effort to embed policy expertise and real-world implementation knowledge into national dementia care strategy.
The addition of clinical leaders like Dr. Samuel S. Giles, a practicing neurologist and chief medical officer at Memory Treatment Centers, underscores another dimension of this growth: bridging the gap between research, policy, and direct patient care. Memory Treatment Centers is a community-based specialty practice focused on Alzheimer’s disease diagnosis and treatment, meaning the federal advisory council now includes voices from the clinical trenches, not just policy rooms. This balance—mixing policy veterans with practicing clinicians—suggests that organizations are preparing to implement larger, more comprehensive dementia care initiatives.
Federal Leadership Expansion and Its Real-World Implications
The expansion of the federal Advisory Council on Alzheimer’s Research, Care, and Services with 10 new members is not a symbolic gesture; it reflects genuine structural growth in national dementia care infrastructure. Adding this many new voices to a federal advisory body typically precedes significant policy shifts, increased funding priorities, or major initiative launches. However, there’s an important caveat: advisory councils only influence policy if government agencies and Congress act on their recommendations. Past federal dementia care councils have issued strong guidance that languished without corresponding budget increases or legislative action, so the real test will be whether these new advisors’ expertise translates into concrete programs and funding.
The appointments also reveal a strategic shift toward “lived experience” leadership. Rather than relying solely on academic researchers or pharmaceutical executives, the council now includes individuals who’ve worked directly with aging services systems and understand the operational challenges of scaling dementia care. Kristi Putnam’s experience managing state human services departments means she understands the budgetary and staffing realities that healthcare organizations face when trying to expand dementia programs. This pragmatic approach to leadership is a meaningful change from earlier council compositions that sometimes favored academic or research-heavy perspectives.
Leadership Transitions at Major Alzheimer’s Organizations
The Alzheimer’s Drug Discovery Foundation (ADDF) experienced a leadership transition when Mark Roithmayr retired from the CEO role effective December 31, 2025. The organization launched a CEO search led by Board Co-Founders Leonard A. and Ronald S. Lauder and President Randal Sandler. This transition, while significant, reveals a thoughtfully managed succession process. Rather than naming an internal successor immediately, the ADDF is conducting a deliberate search, suggesting the organization is looking for specific expertise or a particular leadership style to guide the foundation into its next phase.
Whether the new CEO comes from pharmaceutical development, nonprofit leadership, or patient advocacy will signal the foundation’s strategic direction for the next five years. In parallel, Alzheimer’s Los Angeles has expanded rather than simply replaced leadership. In 2025, the organization strengthened its professional education partnerships and expanded programs including the Care Ecosystem and Enhanced Care Management initiatives. These programs now provide interdisciplinary dementia care support to thousands of healthcare professionals across Southern California. This model—growing existing leadership teams and programs rather than replacing leaders—reflects a different growth strategy than what we see at the ADDF. It prioritizes deepening organizational capacity and expanding the services already in place, rather than betting on a new leader to chart a different course.
How Expanded Leadership Translates to Better Patient Care
When Alzheimer’s care organizations expand their leadership or bring in specialists, the intended outcome is improved patient care and broader program reach. The Alzheimer’s Association’s 2026 strategic initiatives—which include releasing a white paper and guidance for healthcare organizations to build and expand dementia care programs, plus establishing a partnership roundtable—show how expanded organizational leadership enables systemic change. The white paper and roundtable exist because the association has the leadership capacity and organizational resources to coordinate multiple healthcare systems. A smaller organization without this leadership depth couldn’t undertake such initiatives.
However, expansion doesn’t automatically improve care. Healthcare systems often struggle to implement best practices even when they have access to national guidance. A hospital system might read the Alzheimer’s Association’s white paper on building dementia care programs and find itself constrained by budget limitations, physician resistance, or staffing shortages. The leadership at major organizations can provide the roadmap and the partnership support (through the Alzheimer’s Association’s roundtable), but implementation depends on local healthcare leaders having both the will and the resources to act. The expansion of national organizations is most effective when paired with regional and local commitment.
Scaling Challenges and the Reality of Expanding Dementia Care
One of the most important things to understand about leadership growth in the Alzheimer’s field is that expansion at the national level doesn’t automatically solve local access problems. The Alzheimer’s Association, ADDF, and various regional providers are all growing their leadership and programming, yet dementia care remains unevenly distributed across the United States. Rural areas, low-income neighborhoods, and underserved regions still face severe shortages of dementia specialists, geriatric care managers, and quality assisted living facilities. National leadership can set standards and provide guidance, but the actual work of building dementia care infrastructure happens locally, often constrained by regional economics and physician supply.
There’s also a tension worth acknowledging: as major organizations grow their leadership and programs, they often become more professionalized and removed from individual patients. An expanded Alzheimer’s Association with more advisors and staff members can influence policy, but patients needing help today rely more directly on their local care providers. The leadership growth we’re seeing represents a long-term strategic investment in the dementia care field, but it’s not a solution to immediate access gaps. Families seeking Alzheimer’s care resources today still face the same barriers they faced before these leadership changes took effect.
Professional Education as a Growth Priority
A notable pattern in these organizational changes is the emphasis on professional education. Alzheimer’s Los Angeles specifically highlighted its expanded professional education partnerships and training programs as part of its growth strategy. This reflects a recognition that Alzheimer’s care is constrained not just by the number of specialists available, but by the number of healthcare professionals who understand dementia care best practices. By expanding education and training programs, organizations can multiply their impact: one neurologist can teach 50 nurses, who can each care for 20 patients.
The Alzheimer’s Association’s partnership roundtable similarly focuses on enabling healthcare organizations to build their own dementia care programs rather than simply referring patients elsewhere. This is a force-multiplier approach to organizational growth. Instead of hiring more specialists directly, these organizations are training existing healthcare professionals to implement dementia care within their current institutions. This model works well when the training is high-quality and the local organizations have genuine commitment, but it requires ongoing support and coordination—which is why the expansion of leadership at major organizations is strategically important.
Looking Forward: What These Leadership Changes Suggest About the Field’s Direction
The pattern of leadership growth, federal advisory expansion, and professional education initiatives suggests that the Alzheimer’s care field is preparing for a significant scaling phase. The aging Baby Boomer population means the number of Americans with dementia will only increase over the next decade, and organizations are positioning themselves to meet that demand. The diversity of new federal advisors—from policy experts to practicing clinicians—suggests that upcoming initiatives will try to bridge the gap between what research shows works and what healthcare systems can actually implement.
One realistic outlook: over the next 3-5 years, we’ll likely see more dementia care programs launch in mainstream healthcare settings, more professional training initiatives directed at primary care physicians and nurses, and more policy guidance aimed at healthcare systems. Whether these programs will be adequately funded, whether they’ll reach underserved communities, and whether they’ll actually reduce the burden on families remains to be seen. But the organizational groundwork is clearly being laid.
Conclusion
Leadership changes at major Alzheimer’s care organizations signal genuine organizational growth and a shift toward scaling dementia care services across the United States. The federal advisory appointments bring policy expertise and clinical experience to national strategy-setting, while organizations like the Alzheimer’s Association and regional providers are expanding their programs and professional education initiatives. These changes reflect a recognition that dementia care is constrained by more than just the number of specialists available—it’s also limited by how many healthcare professionals understand dementia best practices and how many healthcare systems have built dementia care into their standard operations.
For patients, families, and healthcare professionals, these leadership changes represent both opportunity and cautious optimism. The national infrastructure for dementia care is becoming more sophisticated and better coordinated. At the same time, access remains uneven, implementation of best practices remains inconsistent across healthcare systems, and the immediate shortage of dementia specialists continues. The leadership growth we’re seeing is a necessary first step toward a more robust dementia care system, but it will ultimately succeed or fail based on how effectively local healthcare organizations implement the guidance and programs these national leaders are developing.
You Might Also Like
- Abandoned Urban Real Estate Transforms Into Senior Housing With Care Services
- How Expanded Collections Help Older Adults and Their Caregivers Cope
- Caregivers Get Professional Help Healing From Extended Occupational Stress Effects
For more, see Alzheimer’s Association — medical tests.
